Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analyses-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analyses

Published:2020-12-29 Issue:1 Volume:100 Page:79-91
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Sarikonda Ghanashyam¹,Mathieu Mélissa²,Natalia Mahwish³,Pahuja Anil¹,Xue Qiong³,Pierog Piotr L.³^ORCID,Trampont Paul C.⁴,Decman Vilma⁵,Reynolds Susan⁶,Hanafi Laïla‐Aïcha²,Sun Yongliang S.⁷,Eck Steven⁸,Hedrick Michael N.⁷,Stewart Jennifer J.⁹,Tangri Shabnam¹,Litwin Virginia²,Dakappagari Naveen¹

Affiliation:

1. Navigate BioPharma Services, Inc., a Novartis subsidiary Carlsbad California USA

2. Caprion Biosciences Inc Montréal Québec Canada

3. Takeda Pharmaceutical International Cambridge Massachusetts USA

4. Nexelis Seattle Washington USA

5. GlaxoSmithKline Collegeville Pennsylvania USA

6. Curiox Biosystems Boston Massachusetts USA

7. Bristol Myers Squibb Lawrenceville New Jersey USA

8. Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca Gaithersburg Maryland USA

9. Flow Contract Site Laboratory Bothell Washington USA

Funder

Dana-Farber Cancer Institute

Navigate BioPharma

American Association of Pharmaceutical Scientists

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.21985

Reference29 articles.

1. Early immunologic correlates of HIV protection can be identified from computational analysis of complex multivariate T-cell flow cytometry assays*

2. Circulating Tumor Cell Analysis: Technical and Statistical Considerations for Application to the Clinic

3. Recommendations for the evaluation of specimen stability for flow cytometric testing during drug development

4. Flow cytometric method transfer: Recommendations for best practice

5. More than just quality control;Carey J. L.;Clinics in Laboratory Medicine,2007

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Finding Your CAR;The American Journal of Pathology;2024-08

2. Implementation of flow cytometry testing on rare matrix samples: Special considerations and best practices when the sample is unique or difficult to obtain;Cytometry Part B: Clinical Cytometry;2024-07-20

3. Accelerating the development of genetically engineered cellular therapies: a framework for extrapolating data across related products;Cytotherapy;2024-07

4. 2023 White Paper on Recent Issues in Bioanalysis: ISR for ADA Assays, the Rise of dPCR vs qPCR, International Reference Standards for Vaccine Assays, Anti-AAV TAb Post-Dose Assessment, NanoString Validation, ELISpot as Gold Standard (Part 3 – Recommendations on Gene Therapy, Cell Therapy, Vaccines Immunogenicity & Technologies; Biotherapeutics Immunogenicity & Risk Assessment; ADA/NAb Assay/Reporting Harmonization);Bioanalysis;2024-02-22

5. Flow cytometry: Aspects and application in plant and biological science;Journal of Biophotonics;2023-12-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3